By Alicia Gallegos, amednews staff Physicians’ prescribing data can continue to be sold for marketing purposes, the Supreme Court rules. Manufacturers of generic drugs are not responsible for brand-name labeling errors. Brand-name and generic drug manufacturers have prevailed in two U.S. Supreme Court cases that could have wide-reaching effects on physicians who prescribe drugs and […]